Literature DB >> 18326747

Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.

Claudio Campa1, Ian Kasman, Weilan Ye, Wyne P Lee, Germaine Fuh, Napoleone Ferrara.   

Abstract

PURPOSE: The purpose of this study was to evaluate different methods of detecting and quantifying experimentally induced choroidal neovascularization (CNV) and vascular changes induced on CNV by an anti-VEGF-A monoclonal antibody.
METHODS: Choroidal neovascularization was induced by 532-nm diode laser in C57BL/6 mice. Ten days after the laser, the following methods were used to detect the new vessels: high-resolution angiography with fluorescein isothiocyanate-dextran; immunohistochemistry with biotinylated isolectin, rabbit anti-NG2, rat anti-CD31, rabbit anti-VWF, rat ani-CD105, rabbit anti-collagen IV, rat anti-ICAM-2, rabbit anti-desmin, and rat anti-MECA 32; and intravital injection of fluorescein-labeled Lycopersicon esculentum (tomato) lectin. To verify the validity of these staining methods in the quantification of treated CNV, the authors applied the most effective of these techniques to three groups of mice after laser induction of CNV and treatment with an anti-VEGF full antibody (G6-31).
RESULTS: Fluorescein isothiocyanate-dextran angiography, rat anti-ICAM-2 immunostaining, and tomato lectin intravital injection resulted in the most effective means of identifying choroidal neovascularization. A certain amount of nonspecific fluorescence was detected in the area of CNV for each
METHOD: This fluorescence appeared more intense when fluorescein isothiocyanate-dextran was used. Tomato lectin injection and rat anti-ICAM-2 immunostaining were the methods that better recorded the antiangiogenic drug effect.
CONCLUSIONS: Because of easy execution, low background fluorescence, and detailed visualization of new vessels, intravital injection of tomato lectin followed by a quantification based on threshold fluorescence represents the best technique for measuring CNV and the vascular changes induced by anti-VEGF-A monoclonal antibody in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326747     DOI: 10.1167/iovs.07-1194

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

3.  Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.

Authors:  Bärbel Rohrer; Beth Coughlin; Mausumi Bandyopadhyay; V Michael Holers
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-06       Impact factor: 2.671

4.  Rac1 activates HIF-1 in laser induced choroidal neovascularization.

Authors:  Peng Zhang; Xing Zhang; Jiang-Li Fan; Xiao-Feng Hao; Yu-Sheng Wang; Yan-Nian Hui; Dan Hu; Jian Zhou
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

5.  VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.

Authors:  Chul Han; Se-Woon Choe; Yong Hwan Kim; Abhinav P Acharya; Benjamin G Keselowsky; Brian S Sorg; Young-Jae Lee; S Paul Oh
Journal:  Angiogenesis       Date:  2014-06-24       Impact factor: 9.596

6.  A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Authors:  Rania S Sulaiman; Judith Quigley; Xiaoping Qi; Michael N O'Hare; Maria B Grant; Michael E Boulton; Timothy W Corson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-10       Impact factor: 2.671

7.  Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.

Authors:  Nathaniel Parsons; Balasubramaniam Annamalai; Elisabeth Obert; Gloriane Schnabolk; Stephen Tomlinson; Bärbel Rohrer
Journal:  Mol Immunol       Date:  2019-02-12       Impact factor: 4.407

8.  Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

Authors:  Sara Moghaddam-Taaheri; Monica Agarwal; Juan Amaral; Irina Fedorova; Elvira Agrón; Norman Salem; Emily Chew; S Patricia Becerra
Journal:  J Clin Exp Ophthalmol       Date:  2011-10-23

9.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

10.  Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse.

Authors:  Kristopher G Sheets; Yongdong Zhou; Monica K Ertel; Eric J Knott; Cornelius E Regan; Jasmine R Elison; William C Gordon; Per Gjorstrup; Nicolas G Bazan
Journal:  Mol Vis       Date:  2010-03-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.